Sex differences in amyloid transthyretin cardiomyopathy National Amyloidosis Centre staging at diagnosis: an analysis from a large single-center cohort

Background

Amyloid transthyretin cardiomyopathy (ATTR-CM) is a progressive infiltrative cardiomyopathy that has seen significant advances in diagnosis and treatment over the last two decades. Sex differences in phenotype, treatment response, and long-term outcomes remain poorly understood. Our study aims to describe the factors that contribute to differences in phenotype and long-term outcomes between male and female patients.